@GPetranyii
iAccount based inUnited States
About this account
- Account based in
- United States
- Connected via
- United States App Store
Account-level information from X, not a live location or the device used for a specific post.
Infectious Diseases doc
Joined March 2020
- Tweets39
- Following53
- Followers22
- Likes138
Gyula Michael Petranyi retweeted
NOT AGAIN —
Over the past decade, the U.S. has steadily increased the number of residency positions, reaching 43,237 total positions in 2025, the highest ever.
Yet even with that growth, the system still struggles to fully align supply with demand.
Every year, 93–94% of U.S. MD seniors match, and over 92% of DO seniors match, meaning the vast majority of U.S. graduates secure positions.
At the same time, nearly 10,000 international medical graduates (IMGs) matched into U.S. residency programs in 2025, filling critical gaps in the system.
Even after the main match, 2,500+ residency positions remained unfilled and had to be offered through SOAP, a process specifically designed to fill vacancies that U.S. grads did not take.
IMGs are not “taking” spots at scale, they face much lower match rates (≈58–68%) compared to U.S. graduates, meaning they are competing for and often filling the positions others leave behind.
The facts remain
— U.S. grads overwhelmingly match at high rates
— Certain specialties and locations remain undesirable
— And thousands of positions would go unfilled without IMGs
Without international doctors, entire parts of the U.S. healthcare system, especially rural and primary care, would be understaffed.
How did we end up wanting to blow up everything that adds value to America?
Over the past 10 years, the US has seen a steady rise in foreign medical students taking US student residency spots.
Every year, 1000+ US medical students fail to match, while 6000+ FMGs do match. About half of unmatched students find a spot, but they must still compete with FMGs for the leftover positions, leaving 500 - 600 US medical students with a worthless medical degree.
Gyula Michael Petranyi retweeted
Cash transfers to individuals that the U.S. government made during the Covid pandemic demonstrated how such a policy tool could help address the political–economic determinants of health. Read the Medicine and Society article by Eric Reinhart, M.D.: nej.md/3Uc70MA
Gyula Michael Petranyi retweeted
The moral clarity of WHO's Director-General. thelancet.com/journals/lance…
Cheers, I'm putting this in my CV.
Our warmest congratulations to Professor Katalin Karikó and the Hungarian people on winning the #NobelPrize for Medicine for her life-saving research.
May she continue to inspire many generations of young scientists to come. @kkariko
Gyula Michael Petranyi retweeted
Boesen K, Ioannidis JPA.
Medical advertisements and scientific journals: Time for editors and publishers to take a stance.
J Eval Clin Pract. 2023 Feb 19. doi:10.1111/jep.13816 onlinelibrary.wiley.com/doi/…
Gyula Michael Petranyi retweeted
Please keep perspective. We have a new VOC Omicron, but do not forget that VOC Delta is dominant worldwide & people are drying unnecessarily because we do not have #VaccinEquity
We must ⬆️ vaccination among those most at risk in all countries & drive ⬇️ transmission everywhere.
The Technical Advisory Group on SARS-CoV-2 Virus Evolution met today to review what is known about the #COVID19 variant B.1.1.529.
They advised WHO that it should be designated a Variant of Concern.
WHO has named it Omicron, in line with naming protocols bit.ly/3r8YrEd
Gyula Michael Petranyi retweeted
On the Pfizer COVID-19 vaccine: publishing interim results through a press release is neither good scientific practice nor does it help to build public trust in vaccines. An announcement should come with full publication of a peer-reviewed research paper in a scientific journal.